Exploring the Efficacy of Digital Therapeutics for Anxiety and Depression

Abstract

Anxiety and depression are among the most common mental health disorder diagnoses. It is of utmost importance to address these and other psychological disorders at the appropriate time within a global healthcare system that is making rapid advancements in the field of technology. The primary objective of this study is to explore the efficacy and summary of the effectiveness and subjective results of some selected digital therapeutics currently available on the market for users suffering from anxiety and depressive disorders. The next aim of this work is to report subjective patient-based outcomes within a specific digital therapeutic cohort. Results showed that the trial population compared to scores at baseline improved 66% more effectively compared to a psychopharmacological substance. One of the most critical contributions to mental healthcare in recent years is the advancement of technology with the introduction of digital solutions in this sector. The growing range of application options available has the potential to fundamentally change traditional therapeutic approaches in the future, offering a range of groundbreaking potential benefits for patients with psychological disorders. The adoption of telemedicine modalities, including digital health solutions, to complement current clinical practice represents a fundamental step in optimizing healthcare and treatment access. Clinical data have shown that one digital mental health solution gained positive and significant results in major depression in terms of as a primary endpoint.